Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis.

Mol Ther Oncolytics

Department of Thoracic Surgery, State Key Laboratory of Pharmaceutical Biotechnology, Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210093, China.

Published: June 2022

Tumor cells can evade attack by phagocytes by upregulating the self-marker CD47. The mechanisms underlying tumor CD47 upregulation, however, remain unclear. Here, we report that human lung adenocarcinoma CD47 is upregulated by interferon-γ (IFN-γ), the level in the tumor microenvironment of which is markedly increased after tumor metastasis and chemotherapy. The IFN-γ receptor is expressed in various human lung adenocarcinoma tissues regardless of the CD47 protein expression, and lung adenocarcinoma CD47 expression is significantly enhanced following tumor metastasis or chemotherapy treatment. In line with this, CD47 expression in various lung cancer cells is markedly increased by IFN-γ treatment. Mechanistically, IFN-γ promotes CD47 expression by activating interferon regulatory factor-1 (IRF-1), which binds to an IRF-1-binding domain within the CD47 promoter region and increases CD47 transcription. Functionally, IFN-γ-enhanced CD47 expression facilitates human lung cancer cell invasion both and , whereas IFN-γ-induced CD47 upregulation and cancer metastasis are blocked by mutating the IRF-1-binding site within the CD47 promoter. Our results reveal IFN-γ-enhanced CD47 expression as a novel mechanism promoting human lung adenocarcinoma progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127120PMC
http://dx.doi.org/10.1016/j.omto.2022.04.011DOI Listing

Publication Analysis

Top Keywords

human lung
20
lung adenocarcinoma
20
cd47 expression
20
cd47
14
adenocarcinoma cd47
12
tumor metastasis
12
cd47 upregulated
8
upregulated interferon-γ
8
cd47 upregulation
8
markedly increased
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!